Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Xiao Tu is active.

Publication


Featured researches published by Xiao Tu.


Oncogene | 2000

IGF-I receptor signaling in a prostatic cancer cell line with a PTEN mutation.

Krzysztof Reiss; Jin-Ying Wang; Gaetano Romano; Frank Furnari; Webster K. Cavenee; Andrea Morrione; Xiao Tu; Renato Baserga

LNCaP prostatic cancer cells are characterized by having a PTEN mutation, low levels of type 1 insulin-like growth factor receptor (IGF-IR) and no IRS-1, one of the major substrates of the IGF-IR. The absence of IRS-1, an activator of PI3-kinase, is compensated in these cells by the mutation in PTEN, an inhibitor of PI3-kinase. However, IGF-IR signaling in the absence of IRS-1 can cause cell differentiation and growth arrest. We hypothesized that these three characteristics may not be unrelated, specifically that, together, they may favor the metastatic spread of prostatic cancer cells without decreasing their growth potential. In support of this hypothesis, we report here that: (1) IRS-1 expression increases cell adhesion and decreases cell motility; (2) over-expression of the IGF-IR, in the absence of IRS-1, causes growth arrest and (3) a combination of IGF-IR and IRS-1 restores the transformed phenotype of LNCaP cells. These findings suggest a mechanism by which prostatic cancer cells can achieve metastatic potential without interfering with their growth potential.


Oncogene | 2001

Mechanisms of regulation of cell adhesion and motility by insulin receptor substrate-1 in prostate cancer cells

Krzysztof Reiss; Jin-Ying Wang; Gaetano Romano; Xiao Tu; Francesca Peruzzi; Renato Baserga

LNCaP cells are human prostatic cancer cells that have a frame-shift mutation of the tumor suppressor gene PTEN and do not express the insulin receptor substrate-1 (IRS-1), a major substrate of the type 1 insulin-like growth factor receptor (IGF-IR). Ectopic expression of IRS-1 in LNCaP cells increases cell adhesion and decreases cell motility by an IGF-I-independent mechanism. We show now that these effects of IRS-1 are accompanied by serine phosphorylation of IRS-1 and are inhibited by inhibitors of phosphatidylinositol 3-kinase (PI3K). We have confirmed the requirement for PI3K activity and serine phosphorylation by the use of IRS-1 mutants, expressed in LNCaP cells. Serine phosphorylation inhibits IGF-I-induced tyrosyl phosphorylation of IRS-1, which is restored by the expression of wild-type PTEN or by inhibition of PI3K activity. Finally, IRS-1 in LNCaP cells co-immunoprecipitates with integrin α 5 β 1, and the association is again IGF-I-independent. We conclude that in LNCaP cells, IRS-1 is serine phosphorylated by PI3K, generating effects that are different, and even opposite, from those generated by IGF-I.


Experimental Cell Research | 2003

Intracellular redistribution of nuclear and nucleolar proteins during differentiation of 32D murine hemopoietic cells

Xiao Tu; Raffaele Baffa; Stephen Luke; Marco Prisco; Renato Baserga

We have investigated the intracellular localization of four proteins in murine hemopoietic 32D and 32D-derived cells during exponential growth and after induction of differentiation. The four proteins studied were the insulin receptor substrate-1 (IRS-1), the ID2 protein, nucleolin, and the upstream binding factor (UBF), all of which are involved directly or indirectly in the differentiation program. These four proteins were found to be predominantly nuclear (and/or nucleolar) during exponential growth, as expected. In three models of induced differentiation along the granulocytic pathway, IRS-1, ID2, and nucleolin shifted in part to the cytoplasm, where their levels eventually decreased. UBF also disappeared during differentiation, but we could not detect a cytoplasmic shift in this protein. These experiments indicate that induction of granulocytic differentiation in 32D and 32D-derived cells is accompanied by intracellular redistribution of proteins. This nucleo-cytoplasmic shuttle may play a significant role in the changes in gene expression that occur during differentiation.


Oncogene | 2004

Role of pescadillo in the transformation and immortalization of mammalian cells

Arianna Maiorana; Xiao Tu; Guanjun Cheng; Renato Baserga

The murine and human homologs of the zebrafish pescadillo protein (Pes1 and PES1, respectively) play important roles in ribosome biogenesis and DNA replication. We investigated the effect of Pes1 on the growth of mouse embryo (3T3-like) fibroblasts and conditionally immortalized human fibroblasts expressing the SV40 T antigen (AR5 cells). Increased expression of Pes1 causes transformation of mouse and human fibroblasts in culture (colony formation in soft agar). Although Pes1 can replace the SV40 T antigen in inducing colony formation in soft agar, it cannot substitute the T antigen in the immortalization of human fibroblasts, indicating that it distinguishes between the two functions. As the biological effects of Pes1 are similar to those of the insulin receptor substrate-1 (IRS-1), we investigated the interactions of Pes1 with IRS-1 itself and with the SV40 T antigen. The Pes1 protein (which localizes to the nuclei and nucleoli of cells) interacts with both IRS-1 and the SV40 T antigen, and markedly decreases the interaction of T antigen with p53. Taken together, these results suggest mechanisms for the ability of Pes1 to transform cells, and its failure to immortalize them.


Gene Therapy | 2001

Efficient in vitro and in vivo gene regulation of a retrovirally delivered pro-apoptotic factor under the control of the Drosophila HSP70 promoter.

Gaetano Romano; Krzysztof Reiss; Xiao Tu; Francesca Peruzzi; B Belletti; Jin Ying Wang; Tommaso Zanocco-Marani; Renato Baserga

We have developed a self-inactivating retroviral vector system with an internal, inducible Drosophila HSP70 promoter. This vector system delivers the desired transgene into cells rapidly and efficiently. It generates mixed populations of transduced cells where the transgene is inducible, and does not require the isolation of specific clones. Since the transgene is not expressed (or poorly expressed) at the restrictive condition (34°C), mixed populations can be selected in which tumor suppressors or other inhibitory genes can be strongly induced upon changing the conditions (39°C or the plant amino acid L-canavanine). This retroviral vector should be very useful for the expression of sequences that are poorly tolerated by cells, and is also active in animals.


Cancer Research | 2006

A Mechanism for Cell Size Regulation by the Insulin and Insulin-Like Growth Factor-I Receptors

Hongzhi Sun; Xiao Tu; Renato Baserga

Deletion of the type 1 insulin-like growth factor receptor (IGF-IR) or of the insulin receptor substrate-1 (IRS-1) genes in animals causes a 50% reduction in body size at birth. Decrease in body size is due to both a decreased number of cells and a decreased cell size. Deletion of the insulin receptor (InR) genes results in mice that are normal in size at birth. We have used 32D-derived myeloid cells to study the effect of IGF-IR and InR signaling on cell size. 32D cells expressing the IGF-IR and IRS-1 are almost twice as large as 32D cells expressing the InR and IRS-1. A mechanism for the difference in size is provided by the levels of the upstream binding factor 1 (UBF1), a nucleolar protein that participates in the regulation of RNA polymerase I activity and rRNA synthesis and therefore cell size. When shifted to the respective ligands, UBF1 levels decrease in cells expressing the InR and IRS-1, whereas they remain stable in cells expressing the IGF-IR and IRS-1. The expression of the IGF-IR and IRS-1 is crucial to the stability of UBF1.


Journal of Cellular Biochemistry | 2007

Downregulation of the upstream binding factor1 by glycogen synthase kinase3β in myeloid cells induced to differentiate

Mingli Liu; Xiao Tu; Giovanna Ferrari-Amorotti; Bruno Calabretta; Renato Baserga

The upstream binding factor 1 (UBF1), one of the proteins that regulate the activity of RNA polymerase I, is downregulated in 32D myeloid cells induced to differentiate into granulocytes, either by the type 1 insulin‐like growth factor (IGF‐1) or the granulocytic colony stimulating factor (G‐CSF). Downregulation of UBF1 is largely due to protein degradation, while mRNA levels are not affected. Inhibition of UBF1 degradation by lithium chloride (LiCl)and lactacystin suggest a role of glycogen synthase kinase β (GSK3β) in a proteasome‐dependent degradation of UBF. GSK3β phosphorylates in vitro and in vivo the UBF protein, which has five putative motifs for phosphorylation by GSK3β. Elimination and/or mutations of these motifs stabilize the UBF1 protein even in cells induced to differentiate. Conversely, a stably transfected, constitutively active GSK3β accelerates the downregulation of UBF1. We show further that activation of the differentiating protein C/EPBα in 32D cells transformed by the oncogenic BCR/ABL protein causes downregulation of UBF1. Finally, inhibition of differentiation of myeloid cells by a dominant negative mutant of Stat3 stabilizes the UBF1 protein, while rapamycin‐induced differentiation of myeloid cells downregulates UBF1 levels. Taken together, our results indicate that the induction of granulocytic differentiation in 32D murine myeloid cells causes the degradation of UBF1, via GSK3β and the proteasome pathway. J. Cell. Biochem. 100: 1154–1169, 2007.


Journal of Cellular Physiology | 2007

Dual regulation of upstream binding factor 1 levels by IRS-1 and ERKs in IGF-1-receptor signaling

Hongzhi Sun; Xiao Tu; Mingli Liu; Renato Baserga

The Upstream Binding Factor 1 (UBF1) is a nucleolar protein that participates in the regulation of RNA polymerase I activity and ribosomal RNA (rRNA) synthesis. In 32D myeloid cells expressing the type 1 insulin‐like growth factor receptor (IGF‐IR), the UBF1 protein (but not its mRNA) is down regulated when the cells are shifted from Interleukin‐3 (IL‐3) to IGF‐1. Ectopic expression of insulin receptor substrate‐1 (IRS‐1) in these cells inhibits the down‐regulation of UBF1. We now show that the stability of UBF1 in 32D‐derived cells requires also a signal from the extracellular regulated kinases (ERKs). When ERKs signaling is defective, as in cells over‐expressing the insulin receptor (InR) or selected mutants of the IGF‐1R, UBF1 is down‐regulated, even in the presence of IRS‐1. The down‐regulation is corrected by the expression of an activated Ha‐ras, which stimulates ERKs activity. Mutations at threonines 117 and 201 of UBF1, known to be phosphorylated by ERKs, cause its down‐regulation. However, when IRS‐2, instead of IRS‐1, is ectopically expressed in 32D InR cells, ERKs phosphorylation is increased and UBF is stabilized. Taken together, these results indicate that in 32D‐derived myeloid cells expressing either the IGF‐IR or the InR, UBF1 levels are regulated by signaling from both IRS proteins and ERKs. J. Cell. Physiol. 212:780–786, 2007.


Clinical Cancer Research | 1998

Inhibition of tumor growth by a dominant negative mutant of the insulin-like growth factor I receptor with a bystander effect.

Krzysztof Reiss; Consuelo D'Ambrosio; Xiao Tu; Chi Tu; Renato Baserga


Molecular Endocrinology | 2003

Insulin-Like Growth Factor I Receptor Signaling and Nuclear Translocation of Insulin Receptor Substrates 1 and 2

Hongzhi Sun; Xiao Tu; Marco Prisco; An Wu; Ivan Casiburi; Renato Baserga

Collaboration


Dive into the Xiao Tu's collaboration.

Top Co-Authors

Avatar

Renato Baserga

Thomas Jefferson University

View shared research outputs
Top Co-Authors

Avatar

Marco Prisco

Thomas Jefferson University

View shared research outputs
Top Co-Authors

Avatar

Gaetano Romano

Thomas Jefferson University

View shared research outputs
Top Co-Authors

Avatar

An Wu

Thomas Jefferson University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Hongzhi Sun

Thomas Jefferson University

View shared research outputs
Top Co-Authors

Avatar

Andrea Morrione

Thomas Jefferson University

View shared research outputs
Top Co-Authors

Avatar

Barbara Belletti

Thomas Jefferson University

View shared research outputs
Top Co-Authors

Avatar

Ivan Casaburi

Thomas Jefferson University

View shared research outputs
Top Co-Authors

Avatar

Krzysztof Reiss

LSU Health Sciences Center New Orleans

View shared research outputs
Researchain Logo
Decentralizing Knowledge